CEO Statement to Shareholders [Yahoo! Finance]
OSR Holdings, Inc. (OSRH)
Company Research
Source: Yahoo! Finance
As the compliance deadline under the minimum bid requirement of NASDAQ approaches, we recognize that market volatility and uncertainty can weigh on investor sentiment. Periods like this often test confidence, particularly for innovation-driven companies that are building long-term value rather than optimizing for short-term optics. I want to take this opportunity to reaffirm that the fundamentals of OSR Holdings, Inc. remain strong, and that the management team is firmly focused on executing against clearly defined value-creating milestones. Progress on VXM01 Licensing Our Swiss biotech subsidiary, Vaximm AG, continues to make solid progress toward finalizing the global licensing transaction for its lead asset, VXM01. Based on the Binding Term Sheet recently executed with BCM Europe AG, the contemplated transaction structure includes: Up to USD 815 million in development, regulatory, and commercial milestones USD 30 million upfront consideration, consisting of USD 15 millio
Show less
Read more
Impact Snapshot
Event Time:
OSRH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OSRH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OSRH alerts
High impacting OSR Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
OSRH
News
- Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical Wearables as a Catalyst for Accelerated Commercial LaunchPR Newswire
- Vaximm Appoints Sébastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform [Yahoo! Finance]Yahoo! Finance
- Vaximm Appoints Sébastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy PlatformPR Newswire
- Vaximm, an OSR Company, Receives Binding Term Sheet from BCM Europe for Global Exclusive License of VXM01 with $30M Upfront and Up to $815M in MilestonesPR Newswire
- Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings [Yahoo! Finance]Yahoo! Finance
OSRH
Sec Filings
- 1/27/26 - Form 8-K
- 1/14/26 - Form 8-K
- 11/25/25 - Form 8-K
- OSRH's page on the SEC website